Anesthetic Management During Cardiopulmonary Bypass: A Systematic Review

被引:59
|
作者
Barry, Aaron E. [1 ]
Chaney, Mark A. [1 ]
London, Martin J. [2 ]
机构
[1] Univ Chicago, Dept Anesthesia & Crit Care, Chicago, IL 60637 USA
[2] Univ Calif San Francisco, Dept Anesthesiol Serv, San Francisco, CA 94143 USA
来源
ANESTHESIA AND ANALGESIA | 2015年 / 120卷 / 04期
关键词
PLASMA-PROTEIN BINDING; ELECTROENCEPHALOGRAPHIC BISPECTRAL INDEX; HYPOTHERMIC CIRCULATORY ARREST; HEPATIC BLOOD-FLOW; CARDIAC-SURGERY; INTRAOPERATIVE AWARENESS; VOLATILE ANESTHETICS; HIGH-RISK; INFLAMMATORY RESPONSE; ISOFLURANE REQUIREMENTS;
D O I
10.1213/ANE.0000000000000612
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Cardiopulmonary bypass (CPB) required for cardiac surgery presents unique challenges to the cardiac anesthesiologist responsible for providing the 3 most basic facets of any anesthetic: amnesia, analgesia, and muscle relaxation. Unique pathophysiologic changes during CPB result in pharmacokinetic alterations that impact the serum and tissue concentrations of IV and volatile anesthetics. Similarly, CPB causes pharmacodynamic alteration-a that impact anesthetic efficacy. The clinical significance of these alterations represents a "moving target" as practice evolves and the technology of CPB Circuitry advances. In addition, perfusionists choose, modify, and maintain the CPB circuitry and membrane oxygenator. Thus, their significance may not be fully appreciated by the anesthesiologist. These issues have a profound impact on the anesthetic state of the patient. The delivery and maintenance of anesthesia during CPB present unique challenges. The perfusionist may be directly responsible for the delivery of anesthetic during CPB, a situation unique to the cardiac suite. In addition, monitors of anesthetic depth-assessment of clinical signs, hemodynamic indicators, the bispectral index monitor, end-tidal anesthetic concentration, or twitch monitoring-are often absent, unreliable, or directly impacted by the unique pathophysiology associated with CPB. The magnitude of these challenges is reflected in the higher incidence of intraoperative awareness during cardiac surgery. Further complicating matters are the lack of specific clinical guidelines and varying international policies regarding medical device specifications that add further layers of complexity and introduce practice variability both within institutions and among nations. We performed a systematic survey of the literature to identify where anesthetic practice during CPB is evidence based (or not), identify gaps in the literature to guide future investigations, and explore the implications of evolving surgical practice, perfusion techniques, and national policies that impact amnesia, analgesia, and muscle relaxation during CPB.
引用
收藏
页码:749 / 769
页数:21
相关论文
共 50 条
  • [31] Anesthetic technique influences brain temperature during cardiopulmonary bypass in dogs - Commentary
    Murkin, JM
    [J]. ANNALS OF THORACIC SURGERY, 1998, 65 (02): : 460 - 460
  • [32] Anesthetic Management During Electroconvulsive Therapy in Children: A Systematic Review of the Available Literature
    Stein, Alecia L. S.
    Sacks, Stuart M.
    Roth, Joeli R.
    Habis, Mohammed
    Saltz, Samantha B.
    Chen, Catherine
    [J]. ANESTHESIA AND ANALGESIA, 2020, 130 (01): : 126 - 140
  • [33] Heparin Sensitivity and Resistance: Management During Cardiopulmonary Bypass
    Finley, Alan
    Greenberg, Charles
    [J]. ANESTHESIA AND ANALGESIA, 2013, 116 (06): : 1210 - 1222
  • [34] MANAGEMENT OF DIABETIC MELLITUS PATIENT DURING CARDIOPULMONARY BYPASS
    PELLEY, WB
    [J]. JOURNAL OF EXTRA-CORPOREAL TECHNOLOGY, 1976, 8 (04): : 186 - 191
  • [35] Benefits and Risks of Maintaining Normothermia during Cardiopulmonary Bypass in Adult Cardiac Surgery: A Systematic Review
    Ho, Kwok M.
    Tan, Jen Aik
    [J]. CARDIOVASCULAR THERAPEUTICS, 2011, 29 (04) : 260 - 279
  • [36] Arterial blood gas management during cardiopulmonary bypass
    Sanjay O.P.
    Devnath A.
    Thejas B.C.
    [J]. Indian Journal of Clinical Biochemistry, 2005, 20 (1) : 98 - 102
  • [37] MANAGEMENT OF COLD URTICARIA DURING HYPOTHERMIC CARDIOPULMONARY BYPASS
    JOHNSTON, WE
    MOSS, J
    PHILBIN, DM
    GUINEY, TE
    SISSON, JH
    BUCKLEY, MJ
    LOWENSTEIN, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (04): : 219 - 221
  • [38] MANAGEMENT OF A MALIGNANT HYPERTHERMIA PATIENT DURING CARDIOPULMONARY BYPASS
    BYRICK, RJ
    ROSE, DK
    RANGANATHAN, N
    [J]. CANADIAN ANAESTHETISTS SOCIETY JOURNAL, 1982, 29 (01) : 50 - 54
  • [39] MANAGEMENT OF INTRAOCULAR-PRESSURE DURING CARDIOPULMONARY BYPASS
    LARKIN, DFP
    MURPHY, R
    MAGNER, JB
    EUSTACE, P
    [J]. ACTA OPHTHALMOLOGICA, 1987, 65 (05): : 591 - 593
  • [40] Management of exsanguinating hemoptysis during cardiopulmonary bypass - Reply
    Smythe, WR
    [J]. ANNALS OF THORACIC SURGERY, 1999, 68 (06): : 2386 - 2387